Pregnant people nearly twice as likely to develop breakthrough COVID, study suggests


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
Results from a new study suggest pregnant people who are vaccinated against COVID-19 are almost twice as likely to develop breakthrough COVID than those who are not pregnant, The Washington Post reports.
In fact, fully-vaccinated pregnant people "have the greatest risk of developing COVID among a dozen medical states, including being an organ transplant recipient and having cancer," per the Post. The study was based on the medical records of roughly 14 million U.S. patients from the time vaccines first became available.
Findings underscore other research showing how pregnant people or individuals that gave birth recently and contracted COVID are "especially prone" to getting seriously ill from the virus. But this new study extends beyond what "was previously understood" in that it suggests even fully-vaccinated pregnant people "tend to have less protection from the virus than many other patients with significant medical problems."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"If you are fully vaccinated, that's magnificent," said a lead author of the study, David Little. "But if you are fully vaccinated and become pregnant, you remain at higher risk of acquiring covid."
The analysis found that the 110,000 pregnant people included in the study were "90 percent more likely to have been infected with coronavirus than the same number of people who were not pregnant," the Post writes. Those at the next-highest level of risk were organ transplant recipients. And both of those groups shockingly bested immunocompromised patients, who had 60 percent greater odds of coronavirus infection.
Excluded from these findings, however, is the reasoning behind them. "It's definitely interesting," specialist Denise Jamieson told the Post. "This study asks this question but doesn't answer it." Read more at The Washington Post.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Brigid is a staff writer at The Week and a graduate of Syracuse University's S.I. Newhouse School of Public Communications. Her passions include improv comedy, David Fincher films, and breakfast food. She lives in New York.
-
What to know when filing a hurricane insurance claim
The Explainer A step-by-step to figure out what insurance will cover and what else you can do beyond filing a claim
By Becca Stanek Published
-
How fees impact your investment portfolio — and how to save on them
The Explainer Even seemingly small fees can take a big bite out of returns
By Becca Stanek Published
-
Enemy without
Cartoons
By The Week Staff Published
-
You can now get a new Covid booster shot. Should you?
Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber Published
-
FDA to re-evaluate effectiveness of common nasal congestion ingredient
Speed Read
By Justin Klawans Published
-
A flesh-eating bacteria is growing in numbers due to climate change
Speed Read
By Devika Rao Published
-
CDC recommends new RSV vaccine for infants under 8 months
Speed Read
By Devika Rao Published
-
U.S. health agency advises easing federal marijuana restrictions
Speed Read
By Peter Weber Published
-
Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits
Speed Read
By Peter Weber Published
-
Is it time to mask up again?
Today's Big Question A rise in Covid-19 cases brings back the possibility of mask mandates
By Joel Mathis Published
-
The NHS plan for virtual wards to beat winter crisis
feature Patients with respiratory infections to be given wearable devices that allow doctors to monitor them at home
By The Week Staff Published